Episode Transcript
Transcripts are displayed as originally observed. Some content, including advertisements may have changed.
Use Ctrl + F to search
0:05
Hi, everyone. Welcome to
0:07
Febrile, a culture podcast about all things
0:09
infectious disease. We use
0:11
console questions that dive into ID
0:13
clinical reasoning, diagnostics, and antimicrobial
0:15
management. I'm Sarah Dong, your
0:18
host at a MedPeds ID doc. Today's
0:21
episode of Below the Belt is led
0:23
by a team from Australia. First
0:26
up, we have Dr. Morgan Hui. Morgan
0:28
is a basic physician's trainee with
0:30
an interest in infectious diseases. He
0:33
is currently working as an ID
0:35
registrar at Peninsula Health in Melbourne,
0:37
Australia. Hi, it's Morgan, very keen
0:39
to be here today. Dr.
0:42
Jonathan Darby is an infectious diseases
0:44
and general medicine physician. He
0:46
is the head of general medicine
0:48
at St. Vincent's Hospital in Melbourne and
0:51
an associate professor at the University of
0:53
Melbourne. Hi, it's great to
0:55
be here with you today. Dr. Max
0:57
Olensky is an infectious diseases and
0:59
general medicine physician with an interest
1:01
in tropical medicine and infections in
1:03
immunocompromised host. He is the
1:05
current perioperative medicine unit clinical
1:07
lead at Peninsula Health and
1:09
a sectional academic with Monash University
1:11
in Melbourne. Hi, it's
1:13
Max Olensky here. Thanks so much for having us today.
1:15
Really excited for this podcast. Dr.
1:18
Katrina Halliday is the principal hospital
1:20
scientist in charge of the
1:22
Clinical Mycology Reference Lab at the
1:24
University for Clinical Pathology and
1:26
Medical Research and New South Wales
1:28
Health Pathology based at Westmead
1:30
Hospital in Sydney. She is actively
1:32
involved in teaching both scientific
1:34
and medical staff in medical mycology
1:36
and has a strong interest
1:38
in culture independent tests to aid
1:40
in the rapid diagnosis of
1:43
invasive fungal infections and anti -fungal
1:45
drug susceptibility surveillance. Hi,
1:47
it's Katrina Halliday and nice to be
1:49
here too. Wonderful. Thank
1:51
you guys so much for coming. We
1:53
are just going to quickly start by asking
1:55
you to share a little piece of
1:57
culture because we call February everyone's favorite
1:59
cultured podcast. It's really just sharing
2:01
a little something non -medical that you
2:03
like, whether that's pop culture or
2:05
hobbies or other interests that you
2:07
have. So what have you guys
2:09
been enjoying recently? I
2:12
had the pleasure of going to
2:14
see recently for International Women's Day.
2:16
I went to see the RBG
2:18
of many one production about Ruth
2:20
Bader Ginsburg's life, which was fantastic.
2:22
It's one woman show. I think
2:24
it's two of the states and
2:26
it's come back time and time
2:28
again in Australia. Of course, I
2:30
haven't seen it. I was going
2:32
to say that in recent times,
2:34
my daily routine is incorporated the
2:36
New York Times puzzles. I sort
2:38
of churned through them every morning.
2:40
while I'm having my morning coffee.
2:43
And also I've been doing their Crypto Crossword
2:45
of Light to try and get my
2:47
creative juices flowing. Excellent. Love a good puzzle.
2:50
Hi, Morgan. Since COVID,
2:52
I think I've been picking up
2:54
golf after lockdown. Not
2:56
that I play well, but
2:58
it's enjoyable to get outdoors.
3:01
And then in the same vein, I've
3:03
been watching a lot of golf YouTube,
3:05
especially between studying. It's very easy
3:08
watching. And it's just something to
3:10
turn my brain off. And I, which is
3:12
quite good. Yeah. The
3:14
turning your brain off is
3:16
usually a common theme on people's
3:19
suggestions and rounding yourself Jonathan.
3:21
Well, I saw you like travel
3:23
and food. So yesterday, at
3:25
weekend, Australian time, I
3:27
said to my kids, going to cook dinner
3:29
and they requested bao buns. So I made
3:31
bao buns yesterday, which was good fun. Labor
3:33
of love takes most of the day. A
3:35
lot of work. It was very nice. Yeah.
3:38
Very nice. Amazing. I love
3:40
it. Well, thank you guys for
3:42
sharing. All right. Well, Morgan
3:44
is in charge today and is going to take
3:46
us to the case. So I'll hand it
3:48
over. Thank you. So
3:51
today, our case involves a 49 -year
3:53
-old male who presents to the
3:55
renal outpatient department with a form
3:57
of history of a slow -growing painless
3:59
right elbow lesion. He's
4:01
adherent with his immunosuppression and
4:03
a systems review is unrevealed. His
4:06
past medical history includes
4:08
a renal transplant in 2017,
4:10
for primary focal -segmental glomerular
4:12
sclerosis. His pre
4:14
-transplant assessment did not reveal any
4:17
infections for which prophylaxis was
4:19
afforded. His
4:21
early post -transplant course was
4:23
complicated by pulmonary espigelosis, and
4:26
he was treated with a
4:28
six -month course of voriconazole with
4:30
clinical, biochemical, and radiological resolution. At
4:33
the time of seeing him,
4:35
he has a stable allograft function
4:37
currently on low -dose predesalone. Evrolimus
4:39
and Tochrolimus, and his
4:41
co -orbidities include well -controlled hypertension, dyslipidemia,
4:44
steroid induced osteoporosis, and
4:46
gourd. On
4:49
examination, his vitals were normal
4:51
alongside a normal cardiac respiratory exam. His
4:54
abdominal examination revealed a
4:56
non -tender, right -level quadrant mass
4:58
underlying a hockey stick
5:00
scar consistent with a renal
5:02
allegra. Here's a
5:04
1 .5 centimeter non -tender and
5:06
mobile lump on the lateral
5:08
aspect of his right elbow, not
5:11
to the to the underlying skin, without
5:14
notable discolouration, overlying
5:16
skin changes, ingeration,
5:18
no sinus. There
5:20
were no other masses on examination
5:22
of his lympho stations. At
5:25
this point, is there anything else that
5:27
you'd want to ask our patients and what
5:29
differentials do you think that you'd entertain? Thanks
5:32
Morgan, so just to summarise,
5:34
this is a Middle -A's gentleman.
5:36
who's a renal allograft recipient with
5:38
stable function on immunosuppression. His
5:41
post -transplant course was complicated in
5:43
the early stages with pulmonary aspergillosis,
5:45
but he seems to have recovered
5:47
from that with therapy and presents
5:49
now with an incidental painless lump
5:51
on his elbow. Some
5:53
important questions that come to mind
5:55
really are clarification surrounding exposures. For
5:57
instance, what he does for work, what sort
5:59
of hobbies he has, has
6:01
he had any animal contact or
6:03
a little bit more about his sexual
6:05
history. What else is
6:08
important would be whether there are
6:10
other local regional infections or constitutional
6:12
symptoms of note. The
6:14
differential diagnosis for a painless lump in a
6:16
transplant recipient runs the gamut from a
6:18
foreign body reaction to things like a lipoma
6:20
or other soft tissue neoplasms. And
6:22
this includes lymphoma. But considering
6:24
this is through the lens of an
6:26
infection disease approach, I think it's important
6:28
to entertain various sorts of infections and
6:30
likewise we'd entertain things like run -of -the
6:33
-mill bacterial, skin -soft tissue infections like a
6:35
furuncle or a carbuncle, but
6:37
syphilis and cat scratch disease also appear amongst
6:39
the differentials. Considering a significant
6:41
history, fungal ethyl need to
6:43
be entertained, and this includes
6:45
disseminated aspergillosis alongside spore trichosis
6:47
and more rare things like
6:49
mupormycosis or rosopus infection. And
6:52
then the fine print would be things like macrobacterial
6:54
infection, viral or parasitic infections,
6:56
things like TB or non -tibiculus
6:58
macrobacteria. or cysticostasis,
7:00
but those sort of things really
7:03
come to the fore if his
7:05
exposure history was compatible. Taking our
7:07
case a bit further, his social
7:09
history revealed that the patient emigrated
7:11
from the Philippines to Australia 18
7:13
years previously, where he returns to
7:15
visit family and friends every six
7:17
to 12 months, but not at
7:19
recent times. He's a
7:21
long -term heterosexual, monogamous relationship and
7:23
works in maintenance at an
7:25
aged care facility. He's
7:27
a sporadic gardener. with no
7:29
additional epidemiological exposures and
7:31
does not report any recent
7:33
animal nor insect contact
7:35
nor recent local regional infection.
7:38
He consumes no alcohol nor
7:40
smokes tobacco. On
7:43
further history, when pressed, he thinks
7:45
that he might have had the
7:47
onset following a seamlessly innocuous traumatic
7:49
injury against a doorknob without
7:51
skin breach and no set associated
7:53
systemic upset. His
7:55
routine lab results were unremarkable.
7:58
with white cell count, LFTs and
8:00
inflammatory markers within normal limit,
8:02
a stable renal function compared to
8:04
previous, a non -reactive
8:06
RPR and a negative quantifier
8:08
on gold with a good nitrogen
8:10
response. Ultrasonicrophy
8:12
of the lesion revealed
8:14
two small circumscribed ovoid
8:17
masses suggestive of reactive
8:19
lefatinography. This was
8:21
clinically corroborated on surgical
8:23
review and was resected on
8:25
block. with tissue set
8:27
up for histopathological assessment alongside
8:29
routine mycobacterial and fungal
8:31
cultures. No organisms
8:33
were seen from the gram
8:36
and zeal nilson stains nor
8:38
subsequently cultured, however filamentous fungi
8:40
were noted on fluorescent staining.
8:44
Histopathological examination revealed multi
8:46
-nucleated giant cells and
8:48
possible copper penny
8:50
aka medlar bodies. In
8:53
addition, there was a
8:55
suggestion of a brown microcolony
8:57
of hyphel element was suspicion
8:59
for an underlying deep mycosis
9:01
and the specimen was sent
9:03
for further culture and identification. I
9:07
guess now, what do you
9:09
think is meant by deep mycosis
9:11
and how they differentiate? Yeah,
9:13
thanks for that update Morgan on the case.
9:16
To just take a step back,
9:18
this was a subcutaneous leak
9:20
and it didn't have any changes
9:22
on the skin which would
9:25
make us think of an inoculation
9:27
injury but we were certainly
9:29
taken by the history of his
9:31
previous aspergillus infection in the
9:33
lung and wondered if this was
9:35
a site of disseminated infection
9:37
and there is as you've pointed
9:39
out max of broad differential
9:41
in a immunosuppressed transplant patient with
9:43
any lesion. But it was
9:46
an unusual site, it was an
9:48
unusual appearance with relatively few
9:50
other additional symptoms just that it
9:52
brought this mass -like lesion to
9:54
our attention. And
9:56
so to be honest, I hadn't
9:58
really used the term deep mycosis
10:00
in clinical practice before. I
10:03
know it's being raised here and
10:05
has been talked about in some literature,
10:07
but really when we think about
10:09
these lesions, we have a broad differential
10:11
from bungalow to atypical mycobacteria to
10:13
other organisms, which may be indolent and
10:15
slow growing in a transplant patient. But
10:17
this suggestion here with the
10:19
the pigmented nature of the
10:21
fungal element certainly makes us
10:23
concerned about a group of
10:25
fungi which we classify in
10:27
the dematiaceous mold group. This
10:31
is an unusual finding so this
10:33
doesn't happen every day where you
10:35
find this on a biopsy and
10:37
sometimes has been found in further
10:39
other organ sites such as brain
10:41
or life or some itaneous skin
10:43
and soft tissue. So the overarching
10:45
term we would sort of use
10:47
for this would be a pheo
10:50
-mycosis if it is related to
10:52
a pigmented mole. I actually had
10:54
to look up the word pheo
10:56
because I've always wondered where that
10:58
came from. And that's a Greek
11:00
word for dusky. So gray
11:02
or black forming. And
11:04
this is thought to be
11:06
the melanin in this group
11:08
of fungal infections structure that
11:10
causes that appearance. So
11:12
there's a few terms we use
11:15
here. And then the other term
11:17
that we would consider is this
11:19
term of chromoblastomycosis where a chronic
11:21
infection usually due to inoculation but
11:23
it could be dissemination in an
11:25
appropriate host such as this with
11:27
dissemination. There is
11:29
a well -known entity in the
11:31
tropics where these patients have
11:34
a crusted varucous -like lesion
11:36
on the skin with chromoblastomycosis
11:38
and there's a range of
11:40
specific species which are fairly
11:42
geographically distinct depending on where.
11:44
patient may have spent time. And
11:47
so with this individual whilst
11:49
living in residential suburb of Australia,
11:51
we did note that his history is
11:53
from the Philippines and travelling back
11:55
and forth there fairly frequently with some
11:58
sparse gardening. So
12:00
we were concerned about this
12:02
family of organisms from
12:04
that basic microbiological description before
12:06
we had a formal
12:08
culture and identification from our
12:10
Micology Reference Laboratory. The
12:12
next step in his workup
12:14
was the sterile tissue was sent
12:16
to a diagnostic mycology laboratory
12:18
for specialized fungal cultures. From
12:21
here, Catriona will take us through
12:23
exactly what happens in the lab to
12:25
get our diagnosis. Thanks
12:27
very much, Morgan. And
12:30
thank you, John, for that nice history.
12:32
And my, I've now learnt what fire means
12:34
in the fire hypomycosis. I've got a case
12:36
at the moment, so that's good. Okay,
12:38
so when the sample was
12:41
sent to us for culture,
12:43
we already knew that there
12:45
were fungal elements seen histologically.
12:47
When we receive samples in the
12:50
fungal lab, it's really important
12:52
that any tissue samples aren't actually
12:54
ground up. We just make
12:56
them into small pieces and put
12:58
them onto the various agar
13:00
and we don't grind them up
13:02
because if this fungus was
13:04
likely to be, or sometimes we
13:06
don't even know it will
13:08
be, a mucamycete. This particular group
13:10
of fungi are really, really
13:12
fragile and grinding would destroy the
13:15
hyphae and so the organism
13:17
would be non -viable. So
13:19
as a rule, no tissue samples
13:21
are ground up in a mycology laboratory.
13:24
So these sterile pieces of
13:26
tissue were put onto a
13:28
variety of different media. We
13:30
usually use a couple of
13:32
different media. a very general
13:34
purpose media with no antibiotics
13:36
such as sabros dextrose agar
13:38
and then we use more
13:40
nutritious media such as a
13:42
sabros dextrose agar base which
13:44
might have something like brain
13:46
heart infusion and some antibiotics
13:49
like chloramphenicol and gentamicin in
13:51
them to suppress any bacterial
13:53
growth. So following inoculation
13:55
we then use plates but some
13:57
labs do use slopes. the plates
13:59
we seal them with parafilm and
14:01
then we put them in an
14:03
incubator at 30 degrees rather than
14:05
35 degrees which is what would
14:07
be used for most of the
14:09
bacterial growth. And 30 degrees
14:11
I think most fungi are environmental
14:13
organisms and they just do better
14:15
for growing at a slightly lower
14:17
temperature. We keep these
14:19
plates for four weeks and look at
14:21
them every couple of days and
14:23
so the reason that parafilmed is is
14:25
both to keep the
14:28
lids closed, but also prevent
14:30
dehydration when they're put in the
14:32
incubators for quite a long
14:34
time. So that's the reason
14:36
we use that lower temperature. And
14:38
in this particular case, after about
14:40
10 days, we noticed a small
14:42
amount of growth of a dark
14:45
grey fungus growing directly out of
14:47
that tissue. So
14:49
as soon as we get positive
14:51
culture, we would then always
14:53
work in a biological safety cabinet.
14:55
We would then put that
14:58
organism and subculture it onto a
15:00
general purpose saberous agar with
15:02
no antibiotics in it. And we'll
15:04
also prepare a slide culture
15:06
by inoculating a potato dextrose agar
15:09
plate. In order to
15:11
identify fungi in the conventional way,
15:13
you really need to see
15:15
how those fungi are growing in
15:17
their natural state. And so
15:19
for that, you can use macroscopic
15:21
appearance, but the macroscopic appearance
15:23
can change depending on the media
15:25
that you might be using,
15:27
how much light there might be
15:29
exposed to and things like
15:31
that. The macroscopic appearance can be
15:33
a bit of a guide,
15:36
but that microscopic appearance is what
15:38
we need to identify something
15:40
to the genus and ideally the
15:42
species level. So
15:44
you need to use a media
15:46
such as potato, dextrose, agar to
15:48
encourage that sporulation. other
15:50
media that could be used for
15:52
microscopy to prepare slide cultures is
15:54
cornmeal agar, which is probably a
15:56
little bit less nutritious and more
15:59
encouraging of sporulation. So
16:01
in this particular case,
16:03
again, we grew a very
16:05
gray, velvety fungus with
16:07
radial grooves. It changed and
16:09
became a bit darker
16:11
with age on the sabros
16:13
plate, and there was
16:15
a bit of a dark
16:17
exudate or droplets forming
16:19
directly out of that colony.
16:22
The reverse of the colony was also
16:24
dark, so the fact that it
16:26
was dark on the reverse as well
16:29
as on the surface suggests that
16:31
the organism does contain melanin, which fits
16:33
with what was seen histologically. Unfortunately,
16:36
the microscopic appearance of this
16:38
fungus from the slide culture was
16:40
not very helpful. We just
16:42
got hyphaed. We didn't see any
16:44
canidia forming. And so if
16:46
you don't see Canadian warming out
16:48
of that high, we can't
16:50
identify it using conventional methods. Fortunately,
16:53
we have the ability
16:55
to overcome this problem and
16:57
perform DNA sequencing, which
16:59
is actually now considered the
17:01
gold standard for identification of
17:03
fungi. There's a
17:06
couple of different barcoding genes
17:08
for fungo identification that
17:10
we rely upon, the
17:12
internal transcribe spacer region, as
17:14
well as some organisms
17:16
that might identify better with
17:18
something like the elongation
17:21
factor gene. But for this
17:23
particular case, we used
17:25
DNA sequencing of the internal
17:27
transcribe spacer region, as
17:29
well as the D1, D2
17:31
region of the 28s
17:34
ribosomal DNA. We did
17:36
two different PCRs. We
17:38
sent that PCR product off
17:40
for sequencing and ran
17:42
the sequence results against GenBank
17:44
data. databases using a
17:46
blast -in algorithm. And
17:49
I'd never had encountered
17:51
the answer that we got,
17:53
but the answer we
17:55
did get from both the
17:57
ITS sequencing was 99 .4
17:59
% identity to an organism
18:01
called bouncy formasphora lignitalis.
18:03
And I might have butchered
18:05
that pronunciation, but I'm
18:07
happy for someone else to
18:09
correct it. And
18:11
then the next closest match
18:13
was another species within that
18:15
farsie formospora species, but it
18:18
was further away at only
18:20
96 % identity. So we were
18:22
pretty confident that the organism
18:24
we'd come across was this
18:26
lignitalis. We
18:29
did try and do antifungal
18:31
susceptibility testing for this patient,
18:33
but again, with antifungal susceptibility
18:36
testing, you must have
18:38
sporulation and we didn't managed
18:40
to induce sporrelation and therefore
18:42
we weren't able to perform
18:44
antifungal susceptibility testing in this
18:46
particular case. Was it
18:48
far enough away to call it catrinalis or
18:50
not quite? No.
18:54
It makes me feel better that
18:56
you also doubt your pronunciation. I've
18:59
never come across this organism before
19:02
and I haven't even come across
19:04
that genus before. Thank
19:06
you. Thank you so much. I
19:08
guess what? Do we make of
19:10
this and the significance of this organism?
19:12
Would we call it a deep
19:14
mycosis? Yeah. And is it how this
19:16
syndrome typically manifests itself? Well,
19:20
as we've said already, this is
19:22
an unusual organism and I think
19:24
it's been implied as well that
19:26
the world of mycology is forever
19:28
changing and it is difficult to
19:30
keep up with this kaleidoscopic landscape
19:32
of fungal nomenclature. But this syndrome
19:34
is indeed consistent with what we
19:36
call mysotoma. And whilst I am
19:38
no budding biologist. I
19:40
have done my research and we'll
19:42
talk a little bit about mysotoma
19:44
now. It is a chronic granulomatous
19:47
subcutaneous infection caused by several species
19:49
of fungi as well as soil
19:51
inhabiting bacteria, which is endemic within
19:53
this so -called mysotoma bells, which spans
19:55
from 15 degrees south to 30 degrees
19:57
north of the equator and really within
19:59
the tropics of the world. Sporadic
20:01
cases have been reported worldwide, including in
20:03
temperate regions, and it's really quite rare in
20:05
Australia when it does occur. It occurs
20:07
in the northern states and territories at which
20:09
you approach the tropics. We
20:11
make a distinction between actinomycetoma and
20:13
eomycetoma, the form of being caused by
20:15
soil inhabiting bacteria and the latter
20:17
from fungi, such as in this instance.
20:20
And the typical presentation is usually
20:22
with the triad of two
20:24
more sinus tracts. and macroscopic grains,
20:26
which are essentially colonies or
20:29
aggregates of the infectious organism. It
20:31
can extend to adjacent structures,
20:33
including bone, muscle, lymphatics. And
20:36
the classic description from a long,
20:38
long time ago was that of Madura
20:40
foot, named after a region in
20:42
the area called Madurai, where people would
20:44
have stepped on this fungal organism
20:46
that's quite disfiguring. Risk factors, as you
20:48
might gather, are typically environmental or
20:50
related to occupation, and thus it had
20:52
previously been known or sometimes is
20:54
known as an implantation mycosis. And
20:57
risk factors also include, such as
20:59
in this instance, states of immunocompromise, whether
21:01
they be inherited or required. The
21:04
mean age for this sort of syndrome
21:06
is in the 30s and typically occurs
21:08
in males with changing epidemiology based on
21:11
an itinerant population and other regions around
21:13
the world. It usually involves
21:15
the feasts as an implantation mycosis where workers
21:17
might be not wearing shoes and exposed
21:19
to thorns and other things within the soil.
21:21
and less likely to occur in parts
21:23
of the torso, the arms, and other parts
21:25
of the body. Common organisms
21:27
for mycetoma itself, or umycetoma, I
21:29
should say. Maderella mycetomatis, which is
21:31
the classic one, but it's worthwhile
21:34
noting that umycetoma itself is the
21:36
minority of cases of mycetoma. It's
21:38
35 % of cases of mycetoma across
21:40
the board. And within
21:42
umycetoma, Maderella mycetomacus accounts for
21:44
75 % of umycetoma, followed by
21:46
falciformer species. such as the
21:48
other ones that Katrina had
21:50
identified as being similar to
21:52
the falciformis spora lignitalis, which
21:54
was identified in this case.
21:57
And they tend to differ by local
21:59
epidemiology, including climate, vegetation, rainfall, and
22:01
different soil type. Little
22:03
is known about the incubation period between inoculation
22:05
and clinical manifestations, given that
22:07
many patients don't recall a specific predisposing injury,
22:09
such as in this instance. It's
22:12
worth noting that there are atypical
22:14
presentations that typically affect any compromised hosts,
22:16
whereby the classic triad might not
22:18
be present. There are numerous case reports
22:20
out there that highlight a link
22:22
with the tropics in transplant recipients or
22:24
those who are immunoprimised. For instance,
22:26
patients who have migrated from their country
22:28
of origin to a place that
22:30
is not within the mycetoma belt. Some
22:32
40 years later, they're receiving a
22:34
transplant and then having this fungus identified
22:36
from various parts of the body. But
22:39
there's really quite interesting cases
22:41
out there. So beyond clinical suspicion,
22:43
if someone came in with
22:45
a similar presentation, how would you
22:47
go? about
22:49
diagnosing mysotoma. It's
22:51
hard not to have a talk like this
22:53
without saying that clinical impression and an index of
22:55
suspicion are paramount. And they are. So
22:58
the presence of that triad are certainly things that
23:00
would give you an indication. But
23:02
beyond that, in terms of clinching
23:04
the diagnosis, it's a composite of
23:06
growing the organism and pursuing culture.
23:09
Whether that be with a fine needle
23:11
aspirate of growth, wherever it may be
23:13
on the body, with subsequent inoculation under
23:15
plates. I might ask you at this
23:17
instance, Katrina, I know you mentioned that
23:19
tend to culture these only at 30
23:22
degrees, but from my reading, sometimes these
23:24
get inoculated at both 30 degrees and
23:26
37 degrees for a number of weeks,
23:28
because different organisms within this, you must
23:30
atoma syndrome tend to grow predominantly different
23:32
temperatures. Is that fair to say or
23:34
something that always do? Yeah,
23:36
it is a fair enough
23:39
question. I guess we're
23:41
guided by standards for recommending
23:43
what? conditions we do grow
23:45
fungi at and certainly the guideline
23:47
we used is the CLSI guideline which
23:50
the people in the States would
23:52
be very well aware of and they
23:54
make the suggestion that whilst you
23:56
can put things at two different temperatures
23:58
and some labs do put things
24:00
at two different temperatures. Every
24:02
time you put more and more
24:04
plates out you dilute how much sample
24:06
you actually have to be able to
24:08
try and grow things. For
24:10
fungal work, the general recommendation is
24:12
you can just use 30 degrees.
24:15
But you've got to remember, there's also
24:17
plates that get set up for bacterial
24:20
cultures. And there's no reason why many
24:22
of these fungi wouldn't actually grow on
24:24
some of the bacterial plates as well. And
24:26
that is incubated at the higher temperature.
24:28
So we have in my own lab
24:30
times when we get something growing, but
24:32
it's also growing on the bacterial plates
24:34
as well. Great. Thanks
24:37
for that. So beyond culture, the other
24:39
things that are useful in establishing a
24:41
diagnosis include histopathology with evidence of chronic
24:43
granulomidus reaction, and possibly the presence of
24:45
a grain, which given how rare it
24:47
is ought to be discussed directly with
24:49
pathology at your own lab, given that
24:51
this has not seen a great deal.
24:53
And indeed, when we returned to the
24:55
histopathologists and asked them, was that bunch
24:57
of fungi you saw in a conglomerate
24:59
consistent with a grain? And when they
25:01
looked through their textbooks, they confirmed that
25:03
that indeed was the case. So, good
25:05
to have good relationships with the various
25:07
disciplines around the hospital. And
25:10
imaging is used sometimes to determine
25:12
extent of disease, whether it's invading in
25:14
surrounding tissues, but also to suggest
25:16
whether or not there may be improvements
25:18
to help guide duration of therapy.
25:20
I might ask Katrina, lastly, is there
25:22
anything in particular you would say
25:24
about sensitivities? I know we weren't unable
25:27
to achieve sporrelation in this instance,
25:29
but given this was a rare fungus
25:31
and something you hadn't quite encountered
25:33
before clinically. or at a lab level,
25:36
if you were even able to achieve
25:38
spirallation, would there be much to
25:40
be gleaned from undertaking sensitivity testing? Yeah,
25:43
so definitely we would try
25:45
and do susceptibility testing on
25:47
any fungus that grew from
25:49
and was deemed to be
25:51
significant. In this particular
25:53
case, because we couldn't get
25:55
spirallation, we couldn't do susceptibility
25:57
testing. If we had
25:59
been able to do susceptibility testing,
26:02
All we would be able to
26:04
give would be a value of
26:06
what the minimal inhibitory concentration was
26:08
for that particular isolate. But
26:10
that can often give clinicians
26:12
some confidence that whatever drug
26:14
they've decided to treat with,
26:16
you know, is likely to
26:18
be effective or not. There's
26:20
certainly no breakpoints available for
26:22
any of these unusual fungi.
26:24
We really only have breakpoints
26:26
available for one organism. and
26:28
one drug for aspergillus fumigatus
26:30
with boriconazole button. And we
26:33
don't really have breakpoints for anything else. So we're
26:35
really only going to be able to give you
26:37
a number, which may give you confidence as to
26:39
which drug can be used. From
26:41
my experience with testing allatomatiaceous
26:43
fungi, which grow in, you
26:45
know, from cases like this,
26:48
quite often itchoconazole is actually
26:50
really suggests that it is
26:52
quite an effective drug against
26:54
these dark, slow growing. I'm
26:58
not a clinician, but that
27:00
is kind of my experience in
27:03
the lab side of things. As
27:05
you say, I think as clinicians, we
27:07
quite enjoy MICs that are low numbers, but
27:09
appreciate that these are just environmental cutoffs.
27:11
It really comes down to trying to pick
27:14
what you think is going to be
27:16
the most effective agent. Yeah.
27:19
I think it'd be worth
27:22
emphasising that the biopsy is
27:24
ideally an excisional biopsy. because
27:26
it's unusual to get either
27:28
histological diagnosis or an effective
27:30
culture on either an FNA. Sometimes
27:34
a call biopsy, but in this instance,
27:36
we were fortunate enough to have the surgical
27:38
team perform a full excision. And
27:40
I think that's really led to
27:42
an expedited diagnosis in this case.
27:45
I completely agree with that, John. And
27:47
it's the same if we'd have to
27:49
go down the path of using, if
27:51
we hadn't managed to grow it, if
27:53
we'd gone down the path of having
27:56
to use PCR directly from the specimen.
27:58
your ability to get a positive, meaningful
28:00
result from a fine needle aspirate is
28:02
quite a lot lower than it would
28:04
be if you get a nice proper
28:06
tissue specimen. John, how did
28:08
you go on to choose your antifungal
28:11
therapy in this instance? Yeah, so
28:13
that was obviously a little bit
28:15
complicated in the sense that we
28:17
didn't have the full susceptibility data
28:19
to guide us. And
28:21
in these type of infections,
28:23
there's no prospective randomized clinical
28:25
trials to determine the most
28:28
effective drug therapy. But
28:30
we're used to dealing in
28:32
these, let's call it gray zones
28:34
for the theme today in
28:36
ID, where we have to treat
28:38
based on what's being reported
28:40
to work and what we have
28:42
familiarity with. I think
28:44
the surgical adjunctive therapy is really important
28:46
in these cases. If we can
28:48
get local control with the surgical excision,
28:51
then that should be emphasized. However,
28:53
we still wanted to pursue
28:55
some antimicrobial therapy in this
28:57
case. Just recalling
28:59
the case that it is a
29:02
transplant patient on tachyrolimus and everolimus. There
29:04
are a lot of drug
29:06
interactions to consider. And
29:09
reviewing all of the literature in
29:11
the past, a lot of the cases
29:13
have been treated, perhaps in more
29:15
resource -limited settings with ketoconazole, which we
29:17
would rarely use in our setting currently.
29:19
And then each reconnaisal has certainly
29:21
been used as Katrina alluded to. Many
29:24
of the newer studies where
29:26
there have been MYCs reported have
29:28
reported low values to the
29:30
newer triazoles such as vireconazole or
29:32
posiconazole. We did have some
29:34
experience with vireconazole in the past
29:36
with this patient, but perhaps
29:38
given that that was not that
29:41
long ago in a time
29:43
interval, we considered a new agent
29:45
perhaps being a better option
29:47
to switch to. So we decided
29:49
to use posiconazole. This
29:51
certainly had some significant drug
29:53
interactions and really reviewing this carefully
29:55
with our nephrology colleagues and
29:57
looking at the drug interactions. There's
30:00
a significant interaction with
30:02
the cytochrome P450 enzyme
30:04
subset 3A4. And
30:06
so we had to look
30:08
at that and the posiconazole was
30:10
expected to significantly interact
30:12
with dichrolimus so that the initial
30:14
dose of the dichrolimus had to be
30:17
about a third of the baseline
30:19
dosing and the everolimus had to be
30:21
about 50 % of the baseline dosing.
30:24
So the treatment was certainly initiated
30:26
in close consultation with the
30:28
nephrology team. We did that at
30:30
a time when they were
30:32
ready and able to do drug
30:34
levels quite frequently and the
30:36
dichrolimus actually had to come down
30:38
further. So this particular
30:40
patient was on 0 .5
30:42
milligrams BD which eventually
30:44
went down to 0 .05
30:47
milligrams BD in a stepwise
30:49
sequential fashion as the
30:51
levels stayed very high. So
30:54
whilst we look at reports of
30:56
what is expected, it's a lesson
30:58
that you always have to individualize
31:00
these drug -drug interactions. There
31:02
was no ongoing imaging really
31:04
for this particular site because
31:06
we could clinically feel it
31:08
and palpate it very nicely.
31:10
We did review a cerebral
31:12
image, just the completeness, because
31:15
some of these organisms have been known to disseminate
31:17
to the central nervous system, and that was novel.
31:20
And we did repeat his pulmonary
31:22
scan, which had the stable pulmonary
31:24
nodules from his previous pulmonary aspergillosis
31:26
with no change. So we elected
31:28
to treat for six months. This
31:30
was in the time where we
31:32
had another worldwide epidemic going on with
31:34
COVID. And so it was quite
31:36
challenging in terms of monitoring and clinic
31:39
visits, I'll be able to
31:41
get the patient in and
31:43
ensure that he remained symptom free
31:45
after successfully completing the treatment. Thanks
31:50
to Morgan, John, Max
31:52
and Katrina for joining February
31:54
today. Don't forget to check
31:56
out the website Februarypodcast .com where you
31:58
can find the consult notes, are
32:00
written supplements the episodes with links to
32:02
references, our library of ID
32:04
infographics and a link to our merch store.
32:07
February is produced with support from the
32:10
Infectious Diseases Society of America. Please
32:12
reach out if you have any suggestions
32:14
for future shows or to be more involved
32:16
with Febrile. Thanks for listening, stay safe,
32:18
and I'll see you next time.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More